Attending physician at The First Affiliated Hospital of USTC, China
Ang Li is an accomplished clinical researcher and attending physician at the Department of Clinical Laboratory, The First Affiliated Hospital of the University of Science and Technology of China (USTC). With a strong background in medical diagnostics and a specialized focus on microfluidic technologies, he has significantly contributed to the development of advanced biomedical tools for clinical application. His work bridges laboratory science with real-world medical needs, especially in cancer diagnostics and wound care, marking him as a rising expert in translational medical research.
Profile
ORCID
EDUCATION
Ang Li began his academic training in medical laboratory science at Bengbu Medical College, where he earned his Bachelor’s degree in 2017. He continued his education at Anhui Medical University, completing his Master’s degree in Clinical Laboratory Diagnosis in 2020 under the mentorship of Professor Zuojun Shen. Driven by a deep interest in innovative diagnostics, he pursued a PhD in Clinical Medicine at the University of Science and Technology of China, graduating in 2023. Throughout his educational journey, he consistently demonstrated academic excellence and a commitment to medical research.
EXPERIENCE
Following his doctoral studies, Ang Li joined The First Affiliated Hospital of USTC as an attending physician in August 2023. In this role, he is engaged in both clinical diagnostics and scientific research. He plays an integral part in the hospital’s diagnostic laboratory, contributing to assay development, quality control, and translational research. He also collaborates with multidisciplinary teams to implement advanced diagnostic tools, providing valuable insights that enhance patient care and support innovation in laboratory medicine.
RESEARCH INTEREST
Ang Li’s research is centered on the development and clinical application of microfluidic chips and nanomaterials for diagnostics. His primary focus involves the separation and detection of circulating tumor cells using ultrathin membranes, as well as creating Janus films for targeted wound treatment. His interdisciplinary approach combines materials science, biomedical engineering, and clinical laboratory diagnostics, aiming to produce more sensitive, efficient, and patient-friendly diagnostic systems.
AWARD
Ang Li’s groundbreaking research and impactful publications have positioned him as a candidate of merit for prestigious research and clinical excellence awards. His innovative contributions to the separation of circulating tumor cells and biofluid control materials have already gained significant recognition within the scientific community, as demonstrated by the high citation rates of his publications and features in prominent journals. His work stands out for its originality, clinical relevance, and potential to shape the future of diagnostic medicine.
PUBLICATION
-
Ultrathin silicon nitride membrane with slit-shaped pores for high-performance separation of circulating tumor cells, Lab on a Chip, 2022, 22(19): 3676–3686 — This back cover article has been cited by more than 20 studies on cancer diagnostics and microfluidic systems.
-
Wax Direct-Writing of Monolayered Janus Fabrics for Personal Moisture Management, Advanced Materials Interfaces, 2022, 9: 2200438 — Cited by several articles exploring smart textiles and wearable biomedical materials.
-
Elastic Janus film for Wound Dressings: Unidirectional Biofluid Transport and Effectively Promoting Wound Healing, Advanced Functional Materials, 2021, 31(41): 2105265 — Highly cited in the wound healing and smart biomaterials research communities.
These publications reflect Ang Li’s consistent contributions to peer-reviewed research and highlight the interdisciplinary nature of his work, which spans clinical diagnostics, materials engineering, and healthcare innovation.
CONCLUSION
In conclusion, Ang Li demonstrates excellence across academic achievement, clinical research, innovative application, and publication in top-tier journals. His pioneering work in microfluidics and biomedical materials has clear translational potential and addresses pressing medical needs. These attributes make him an outstanding candidate for the Best Researcher Award, and his trajectory indicates he will continue to make impactful contributions to the field of clinical medicine and biomedical engineering.